Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
US Department of Justice
Johnson and Johnson
Boehringer Ingelheim
Fish and Richardson
McKesson
US Army
Colorcon
Chinese Patent Office
Harvard Business School

Generated: January 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 070219

« Back to Dashboard

NDA 070219 describes PROPRANOLOL HYDROCHLORIDE, which is a drug marketed by Actavis Elizabeth, Inwood Labs, Mylan, Nortec Dev Assoc, Rp Scherer, Upsher-smith Labs, Zydus Pharms Usa Inc, Athenex Inc, Baxter Hlthcare Corp, Fresenius Kabi Usa, Hikma Farmaceutica, Sandoz Inc, Smith And Nephew, Solopak, Morton Grove, West-ward Pharms Int, Anda Repository, Ani Pharms Inc, Dava Pharms Inc, Duramed Pharms Barr, Impax Labs Inc, Interpharm, Ipca Labs Ltd, Ivax Sub Teva Pharms, Lederle, Northstar Hlthcare, Par Pharm, Purepac Pharm, Roxane, Sandoz, Schering, Superpharm, Teva, Vintage Pharms, Warner Chilcott, Watson Labs, and Watson Labs Teva, and is included in one hundred and forty-nine NDAs. It is available from fifty suppliers. Additional details are available on the PROPRANOLOL HYDROCHLORIDE profile page.

The generic ingredient in PROPRANOLOL HYDROCHLORIDE is hydrochlorothiazide; propranolol hydrochloride. There are thirty-one drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the hydrochlorothiazide; propranolol hydrochloride profile page.
Summary for 070219
Tradename:PROPRANOLOL HYDROCHLORIDE
Applicant:Vintage Pharms
Ingredient:propranolol hydrochloride
Patents:0
Therapeutic Class:Antimigraine Agents
Cardiovascular Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 070219
Mechanism of ActionAdrenergic beta-Antagonists
Suppliers and Packaging for NDA: 070219
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PROPRANOLOL HYDROCHLORIDE propranolol hydrochloride TABLET;ORAL 070219 ANDA Par Pharmaceutical 0603-5484 0603-5484-21 100 TABLET in 1 BOTTLE (0603-5484-21)
PROPRANOLOL HYDROCHLORIDE propranolol hydrochloride TABLET;ORAL 070219 ANDA Par Pharmaceutical 0603-5484 0603-5484-32 1000 TABLET in 1 BOTTLE (0603-5484-32)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength40MG
Approval Date:Aug 1, 1986TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
US Department of Justice
Medtronic
Argus Health
Merck
Moodys
Cipla
Fuji
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot